Pharmaceutical giants across the world have witnessed higher sales in drugs related to respiratory, anti-diabetic, cardiac therapies due to coronavirus as compared to other drugs. This is because ...

This marks the first time an anti-diabetic medication has been approved for managing this serious sleep disorder. OSA is a condition characterized by intermittent pauses in breathing during sleep ...

Consumers are on board, with an estimated 26% of U.S. adults planning to take a weight loss drug in 2025, according to ...

India's drug price regulator has capped retail prices for 53 drug formulations used in treating various diseases and ...

It also fixed the price of a popular drug combination used to treat type 2 diabetes mellitus—dapagliflozin, teneligliptin, and metformin—at ₹11.60 per tablet, and the price of another anti ...

Sotagliflozin, a newly FDA-approved medication for treating type 2 diabetes and kidney disease with added cardiovascular risks, has been shown to greatly lower the risk of heart attacks and ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows. Not only is ...

and drug stability of current therapies remain limited. Plant-based treatments, which have long been used in traditional medicine, are now being investigated for anti-diabetic properties.